Azilsartan medoxomil,belimumab, and lurasidone hydrochloride |
| |
| Authors: | Daniel A. Hussar Anokhi Shah |
| |
| Affiliation: | 1. Institute of Clinical Medicine and Department of Cardiology, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China;2. Department of Physiology and Key Lab of human Embryonic Stem Cell of Hubei Province, Hubei University of Medicine, Hubei 442000, China;3. Center for Medical Research and Department of Physiology, School of Basic Medical Sciences, Wuhan University, Hubei 430071, China;4. Department of Physiology & Pharmacology, The University of Georgia, Athens, GA 30602, USA;1. Department of Clinical Medicine, Sapienza University of Rome, Rome, Italy;2. Department of Immuno-Rheumatology Unit, Campus Bio-Medico University of Rome, Rome, Italy |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
